Current Rating Overview
MarketsMOJO’s current rating of Sell for Procter & Gamble Hygiene & Health Care Ltd. is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. The Mojo Score stands at 38.0, reflecting a notable decline from the previous score of 50. This score adjustment was made on 29 May 2026, signalling a more cautious stance on the stock’s near-term prospects.
Quality Assessment
Despite the overall Sell rating, the company maintains a good quality grade. This indicates that Procter & Gamble Hygiene & Health Care Ltd. continues to demonstrate solid business fundamentals, including stable operational efficiency and a robust product portfolio within the FMCG sector. However, the quality grade alone is insufficient to offset other concerns impacting the stock’s outlook.
Valuation Considerations
Valuation remains a significant factor in the current rating. As of 19 June 2026, the stock is considered expensive, trading at a price-to-book value of 38.8, which is substantially higher than typical benchmarks. The company’s return on equity (ROE) is an impressive 113.7%, yet this high ROE is accompanied by a premium valuation that may not be justified given the company’s recent financial performance and growth trajectory. Investors should be wary of the elevated valuation multiples, which suggest limited upside potential at current price levels.
Financial Trend Analysis
The financial trend for Procter & Gamble Hygiene & Health Care Ltd. is currently flat. The latest quarterly results for March 2026 reveal a contraction in net sales, which declined by 5.07% to ₹941.32 crores. Earnings per share (EPS) also hit a low of ₹47.17, signalling pressure on profitability. Over the past five years, net sales have grown at a modest annual rate of 4.63%, while operating profit has increased by 5.40% annually. This slow growth, combined with recent quarterly declines, suggests the company is facing challenges in sustaining momentum.
Technical Outlook
From a technical perspective, the stock is rated bearish. Price action over recent months has been weak, with the stock delivering a 1-month return of -3.35% and a 3-month return of -5.30%. More concerning is the 6-month decline of 26.60% and a year-to-date (YTD) loss of 27.51%. Over the past year, the stock has underperformed the BSE500 benchmark consistently, with a 1-year return of -30.21%. This sustained underperformance reflects negative market sentiment and technical weakness, which further supports the Sell rating.
Returns and Market Performance
As of 19 June 2026, Procter & Gamble Hygiene & Health Care Ltd. has delivered disappointing returns to shareholders. The stock’s 1-day gain of 4.09% and 1-week gain of 4.18% offer some short-term relief, but these are overshadowed by longer-term declines. The 1-year return stands at -30.21%, indicating significant erosion of shareholder value. Despite this, the company’s profits have risen by 19.4% over the past year, suggesting some operational resilience amid challenging market conditions. The PEG ratio of 1.8 points to a valuation that is not fully supported by earnings growth, reinforcing the cautious stance.
Comparative Industry Context
Within the FMCG sector, Procter & Gamble Hygiene & Health Care Ltd. is classified as a midcap company. Its valuation and returns profile contrasts with peers, many of which have shown more robust growth and better price performance. The stock’s discount relative to historical peer valuations is limited, and its consistent underperformance against the BSE500 index over the last three years highlights the challenges it faces in regaining investor confidence.
Turnaround taking shape! This Small Cap from NBFC sector just hit profitability with strong business fundamentals showing up. Catch it before the major breakout happens!
- - Recently turned profitable
- - Strong business fundamentals
- - Pre-breakout opportunity
What the Sell Rating Means for Investors
For investors, the Sell rating on Procter & Gamble Hygiene & Health Care Ltd. suggests caution. The combination of an expensive valuation, flat financial trends, and bearish technical signals indicates limited near-term upside and potential downside risk. While the company’s quality remains good, the current market environment and recent performance metrics do not support a more optimistic outlook.
Investors should consider the stock’s recent underperformance relative to benchmarks and peers, alongside its modest growth prospects. The Sell rating advises that capital may be better allocated elsewhere until clearer signs of financial improvement and valuation support emerge.
Summary of Key Metrics as of 19 June 2026
- Mojo Score: 38.0 (Sell)
- Market Cap: Midcap
- Quality Grade: Good
- Valuation Grade: Expensive (P/B 38.8)
- Financial Grade: Flat
- Technical Grade: Bearish
- 1-Year Return: -30.21%
- Net Sales Growth (5 years CAGR): 4.63%
- Operating Profit Growth (5 years CAGR): 5.40%
- EPS (Q4 Mar 2026): ₹47.17
- ROE: 113.7%
- PEG Ratio: 1.8
In conclusion, while Procter & Gamble Hygiene & Health Care Ltd. retains some strengths in quality and profitability, the current valuation and market dynamics justify the Sell rating. Investors should monitor the company’s financial trends and market signals closely before considering any new positions.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
